With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech’s board and management have determined that CGM technology and ...

Trinity Biotech (TRIB) announces the next stage in realizing its comprehensive transformation plan and development of its continuous glucose ...

Trinity Biotech PLC (NASDAQ:TRIB), a leading diagnostic substances company with a market capitalization of $13.12 million, has successfully amended and restated its credit and guaranty agreement, as ...

Trinity Biotech Plc (TRIB) (ISIN: US8964385046)股票专题，提供今日Trinity Biotech Plc(TRIB) (ISIN: US8964385046)股票最新股价查询，实时市场行情，走势图表，及Trinity Biotech Plc(TRIB) (ISIN: ...

Trinity Biotech plc, a biotechnology company specializing in human diagnostics and diabetes management, announced it has secured an additional $4 million in debt financing from Perceptive Advisors.

Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor. Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company ...

都柏林 - 市值1,312万美元的爱尔兰生物技术公司Trinity Biotech plc（NASDAQ:TRIB）宣布从Perceptive Advisors获得额外400万美元债务融资。这笔资金将用于支持公司持续血糖监测（CGM）技术的开发，并推进旨在提高盈利能力和现金流的全面转型计划。根据InvestingPro数据显示 ...

The company has a market cap of $13.59 million, a P/E ratio of -0.33 and a beta of 1.03. Trinity Biotech has a 52-week low of $0.73 and a 52-week high of $3.55. The firm’s fifty day moving ...